Advisor Group Holdings, Inc. Otonomy, Inc. Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.25 - $2.24 $250 - $2,240	1,000 Added 45.45%	3,200 $1,000
Q1 2022 May 04, 2022	BUY	$1.72 - $2.47 $3,096 - $4,446	1,800 Added 450.0%	2,200 $2.44 Million
Q2 2021 Aug 02, 2021	BUY	$2.06 - $2.67 $309 - $400	150 Added 60.0%	400 $1,000
Q1 2021 May 13, 2021	SELL	$2.49 - $6.23 $249 - $623	-100 Reduced 28.57%	250 $1,000
Q3 2020 Nov 12, 2020	BUY	$3.16 - $4.36 $1,106 - $1,526	350 New	350 $1,000

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.